Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hydrogen Innovation Company (THIC) is a specialized biotechnology and medical technology firm focused on the therapeutic application of molecular hydrogen (H2). The company develops and commercializes advanced delivery systems, including hydrogen-rich water generators and inhalation machines, designed to leverage the antioxidant and anti-inflammatory properties of H2. By targeting reactive oxygen species and oxidative stress, THIC aims to provide non-invasive treatments for a variety of conditions such as metabolic syndrome, neurodegenerative disorders, and chronic inflammation. Their products are utilized in both clinical research settings and consumer wellness markets to improve cellular health and recovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Hydrogen Innovation Company.